everolimus
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 2009
b7c7c9a4-994f-43dc-8cd6-cd6eeed6fa89
HUMAN PRESCRIPTION DRUG LABEL
Oct 15, 2023
Mylan Pharmaceuticals Inc.
DUNS: 059295980
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
everolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
everolimus
Product Details
FDA regulatory identification and product classification information